Proteomic Diagnostics--Genetic Alert

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Alert depicts life sciences trends across proteomic diagnostics. Different molecular blood tests and monitoring assays are illustrated across several diseases. The corresponding patent scenario is depicted, along with the industry interactions.The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and

Table of Contents

Proteomic Diagnostics--Genetic AlertTechnology ProfilesMolecular Blood Test for Pulmonary NodulesBlood Test for Colorectal Cancer RiskApplied Proteomics Inc.–SimpliPro Colon™ TestSelected Reaction Monitoring Assay for Cancer DiagnosticsProteomic Technologies for Early DiagnosisAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.